Abstract
Introduction
Tamarindus indica Linn., (Tamarind), family, Leguminosae, is one such widely used medicinal plant. It is found in virtually all tropical climatic regions, from India, Bangladesh through Africa to the Caribbean and South America and up to Southern Florida. Its uses are as varied as the cultures that use it. It is often more difficult to determine which use is more important, as food and beverage [1, 2] or as folklore medicine [2, 3] . In the West African sub-region, including Nigeria, it is widely used as both food and medicine. The pulp has been documented in both the British and American pharmacopoeias as anti-pyretic, antiscorbutic, laxative, carminative and remedy for biliousness and bile disorder [1] [2] [3] [4] [5] and the leaves have antihelmintic and vermifuge properties, destroying intestinal parasites [5] . The work reported here was carried out to validate the medicinal use of this plant in Northern Nigerian folklore.
Materials & Methods

Identification and Collection
Using standard taxonomical methods, supplied by the Bangladesh Forest Research Institute (BFRI), Chittagong, identified the plant's fruits. The fruits of the plant Tamarindus indica Linn. were collected from Baluchora, Chittagong on July 2011 and was identified by a Taxonomist of Bangladesh National Herbarium (BNH). They were then separated & cleaned from impurities. The fruits of the plant were air dried properly. After complete drying, the samples were ground 3 into coarse powder with the help of a mechanical grinder and the powder was stored in a suitable container for extraction process.
Preparation of the Plant Extract
The powdered material was successively extracted with ethanol, acetone and DM water by using cold extraction process [6] . At first 250 gm of dried powder was taken in an aspirator (5L). Before placing powders into the aspirator, the jar was washed properly and dried. Then 750 ml of solvent ethanol was added gradually. The time duration was of 21 days at room temperature with occasional shaking and stirring for each successive extraction. It was then filtered through a fresh cotton plug and finally with a Whatmann Filter paper no. 1. In the same way the powdered material was extracted with acetone. Finally this three extracts were concentrated by rotary evaporator in dry & clean air.
In Vitro Thrombolytic Study
Experiments for clotlysis were carried as reported earlier [7] . Venous blood drawn from healthy volunteers was transferred in different pre-weighed sterile 
Streptokinase (SK) Solution Preparation
To the commercially available lyophilized SK vial (Polamin Werk GmbH, Herdecke, Germany) of 15,00,000 I.U., 5 ml sterile distilled water was added and mixed properly. This suspension was used as a stock from which 100 µl (30,000 I.U) was used for in vitro thrombolysis.
Brine Shrimp Lethality Bioassay Cytotoxic activity [8, 9]
Cytotoxicity of the extract was tested by using brine shrimp lethality bioassay.
Test solution ( Ethanol, Acetone and DM water extract in DMSO) of different concentrations as 5, 15, 30, 60, 120, 240, 300, 350, 400, 450, 500, 550, 600, 650 and 700 µg/ml was applied to the test tubes containing hatched brine shrimp nauplii in sea water followed by counting the survived naupli after 24 h.
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Hatching of Brine Shrimp
For the preparation of sea water 38gm of sodium chloride was weighed, dissolved in distilled water to make 1 liter solution and then filtered off to be a clear solution. This simulated sea water was used for a hatching of brine shrimp.
The shrimp were allowed for two days to hatch and mature as nauplii (larvae).
Preparation of Sample
In a small beaker, measured amount of the sample was accurately weighed and dissolved in DMSO (Dimethylsulfoxide) to give a final concentration of 10mg/ml (10µg/µl).
Application of Test Sample to the Test Tube Containing Brine Shrimp
Nauplii 15test tubes for the sample were taken where each contained 5ml of seawater and 10 nauplii. These test tubes were marked from 1 to 15 for the sample. To test tubes different concentration of sample solution were added to give the concentration of 5µg/ml, 15 µg/ml, 30µg/ml, 60µg/ml, 120µg/ml, 240 µg/ml, 300µg/ml, 350 µg/ml, 400 µg/ml, 450 µg/ml, 500 µg/ml, 550 µg/ml, 600 µg/ml, 650 µg/ml and 700 µg/ml of the sample respectively. Then the samples were subjected to brine shrimp lethality bioassay.
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Preparation of Control Solution
Two control groups were used in Cytotoxicity study, to validate the test method and results obtained due to the activity of the test agent.
Negative Control Test:
In this case, only 30µl DMSO was added in 5ml sea water containing 10 Nauplii.
No extract was added to prepare control solution.
Positive Control Test:
Measured amount of the Vincristine Sulphate (VINCRIRST ®, Techno Drugs
Ltd., Bangladesh) was dissolved in DMSO to get an initial concentration of 3125µg/ml. 9 test tubes for the standard sample were taken where each contained 5ml of seawater and 10 nauplii. These test tubes were marked from 1 to 9. Necessary dilution of Vincristine Sulphate solution was done to get required concentration of the standard sample solution respectively. Standard sample solution concentration were 1.25 µg/ml, 2.5µg/ml, 5µg/ml, 10µg/ml, 15µg/ml, 20µg/ml, 25 µg/ml, 30 µg/ml, 35 µg/ml, 40 µg/ml, 45 µg/ml, 50 µg/ml, 55 µg/ml, 60 µg/ml, 65 µg/ml, 70 µg/ml and 75 µg/ml.
Result Thrombolytic Study
Thrombolytic study results are significant and summarized in table 1 and figure 1. 
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